No connection

Search Results

CHCT

BEARISH
$17.2 Live
Community Healthcare Trust Incorporated · NYSE
Target $18.5 (+7.6%)
$13.23 52W Range $18.22

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$491.43M
P/E
215.0
ROE
1.1%
Profit margin
4.2%
Debt/Equity
1.25
Dividend yield
11.02%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
CHCT exhibits severe valuation misalignment, with a current price of $17.20 trading at a massive premium to its Graham Number ($5.35) and Intrinsic Value ($2.36). While the Piotroski F-Score of 4/9 indicates stable health, the financial fundamentals are undermined by an unsustainable dividend payout ratio of 2356.25% and a trailing P/E of 215.00. Despite a recent 1-year price recovery, the long-term 5-year trend is deeply negative (-52.8%), and the company consistently misses earnings estimates. The high dividend yield is a 'value trap' given that earnings cannot support the current distribution rate.

Key Strengths

Strong short-term liquidity with a Current Ratio of 3.79
Price/Book ratio of 1.08 suggests the stock is trading near its asset value
Recent 1-year price momentum (+23.5%)
Manageable Debt/Equity ratio of 1.25 relative to REIT sector averages
High gross margins (80.51%) typical of healthcare real estate

Key Risks

Mathematically unsustainable dividend payout ratio (2356.25%)
Extreme valuation gap between market price and Graham/Intrinsic values
Chronic history of earnings misses (only 1 of last 4 quarters beat estimates)
Very low Return on Equity (1.13%) indicating poor capital efficiency
Bearish technical trend (10/100) despite recent price spikes
AI Fair Value Estimate
Based on comprehensive analysis
$5.35
-68.9% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
33
Weak
Value
15
Future
45
Past
30
Health
55
Dividend
20
AI Verdict
High-risk value trap
Key drivers: Unsustainable dividend payout, Extreme P/E ratio, Consistent earnings misses, Significant gap to intrinsic value
Confidence
90%
Value
15/100

Ref P/E, PEG, Graham Number

Positives
  • P/B ratio is near 1.0
Watchpoints
  • P/E of 215.00
  • Price is >3x the Graham Number
  • Intrinsic value is only $2.36
Future
45/100

Ref Growth rates

Positives
  • High YoY earnings growth (recovery phase)
  • Forward P/E (43.00) is significantly lower than trailing
Watchpoints
  • Sluggish revenue growth (5.6%)
  • Poor earnings surprise track record
Past
30/100

Ref Historical trends

Positives
  • Recent 6-month recovery
Watchpoints
  • 5-year return of -52.8%
  • Consistent failure to meet analyst expectations
Health
55/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 4/9 (Stable)
  • High Quick Ratio (2.88)
Watchpoints
  • Low ROE and ROA
  • Lack of Altman Z-Score data
Dividend
20/100

Ref Yield, Payout

Positives
  • High nominal yield (11.02%)
Watchpoints
  • Payout ratio of 2356.25% indicates dividend is not covered by earnings

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$17.2
Analyst Target
$18.5
Upside/Downside
+7.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CHCT and closest competitors.

Updated 2026-04-24
CHC
Community Healthcare Trust Incorporated
Primary
5Y
-52.8%
3Y
-36.4%
1Y
+23.5%
6M
+25.3%
1M
+8.9%
1W
-2.4%
AHR
AH REALTY TRUST INC
Peer
5Y
-37.6%
3Y
-35.3%
1Y
-3.8%
6M
-7.0%
1M
+9.8%
1W
+0.8%
BDN
Brandywine Realty Trust
Peer
5Y
-55.0%
3Y
-28.6%
1Y
-35.9%
6M
-22.3%
1M
+8.5%
1W
-2.3%
LAN
Gladstone Land Corporation
Peer
5Y
-36.2%
3Y
-29.2%
1Y
+20.8%
6M
+18.7%
1M
-12.7%
1W
+0.5%
FRP
FRP Holdings, Inc.
Peer
5Y
-8.1%
3Y
-22.7%
1Y
-16.5%
6M
-6.7%
1M
-0.5%
1W
+3.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
215.0
Forward P/E
43.0
PEG Ratio
N/A
P/B Ratio
1.08
P/S Ratio
4.05
EV/Revenue
8.18
EV/EBITDA
13.2
Market Cap
$491.43M

Profitability

Profit margins and return metrics

Profit Margin 4.21%
Operating Margin 19.58%
Gross Margin 80.51%
ROE 1.13%
ROA 1.91%

Growth

Revenue and earnings growth rates

Revenue Growth +5.6%
Earnings Growth +1193.1%
Q/Q Revenue Growth +5.62%
Q/Q Earnings Growth +687.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.25
Moderate
Current Ratio
3.79
Strong
Quick Ratio
2.88
Excellent
Cash/Share
$0.37

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
80.6%
Op. Margin
11.1%
Net Margin
46.6%
Total Assets
$1.0B
Liabilities
$0.6B
Equity
$0.4B
Debt/Equity
1.31x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
58%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2025-10-28
$0.09
+17.4% surprise
2025-04-29
$0.03
-57.1% surprise
2025-02-18
$0.04
-42.9% surprise

Real Estate Sector Comparison

Comparing CHCT against 126 companies in the Real Estate sector (5 bullish, 21 neutral, 100 bearish)
P/E Ratio
215.0
This Stock
vs
40.77
Sector Avg
+427.3% (Expensive)
Return on Equity (ROE)
1.13%
This Stock
vs
-45.9%
Sector Avg
-102.5% (Below Avg)
Profit Margin
4.21%
This Stock
vs
9.14%
Sector Avg
-53.9% (Weaker)
Debt to Equity
1.25
This Stock
vs
2.79
Sector Avg
-55.2% (Less Debt)
Revenue Growth
5.6%
This Stock
vs
22108.13%
Sector Avg
-100.0% (Slower)
Current Ratio
3.79
This Stock
vs
9.68
Sector Avg
-60.8% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

DUPUY DAVID H
Chief Executive Officer
Stock Award
2026-01-15
29,941 shares · $500,015
MONROE WILLIAM G. IV
Chief Financial Officer
Stock Award
2026-01-15
29,605 shares · $494,404
STACH LEIGH ANN
Officer
Stock Award
2026-01-15
17,889 shares · $298,746
GULMI CLAIRE M
Director
Buy
2025-11-21
690 shares · $10,894
COTMAN CATHRINE
Director
Buy
2025-11-04
4,000 shares · $58,640
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-03-12

CHCT filed a Definitive Proxy Statement on March 12, 2026, providing shareholders with necessary information to vote on corporate matters at the upcoming annual meeting.

8-K
8-K
2026-02-17

CHCT filed an 8-K on February 17, 2026, likely to announce its annual financial results for the preceding fiscal year.

10-K
10-K
2026-02-17

CHCT filed its annual 10-K report on February 17, 2026, which includes disclosures regarding its business operations, financial condition, and risk factors. Specific financial highlights and risk details were not provided in the available excerpts.

8-K
FORM 8-K
2026-01-09
8-K/A
FORM 8-K/A
2025-10-29

CHCT filed an amendment to a previously submitted Form 8-K.

8-K
8-K
2025-10-28

CHCT filed an 8-K on October 28, 2025, likely to announce its third-quarter financial results.

10-Q
10-Q
2025-10-28

CHCT filed its 10-Q on October 28, 2025. While specific financial metrics were not provided in the excerpt, the filing includes a dedicated section for Risk Factors under Item 1A.

8-K
8-K
2025-07-29
10-Q
10-Q
2025-07-29

CHCT submitted its 10-Q filing on July 29, 2025. The document identifies 36 distinct risk factors under Item 1A, although specific financial performance metrics were not provided in the available excerpts.

8-K
8-K
2025-05-06
8-K
8-K
2025-05-01
10-Q
10-Q
2025-04-29
8-K
8-K
2025-04-29
DEF 14A
DEF 14A
2025-03-13
8-K
8-K
2025-02-18
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
4 analysts
Truist Securities
2026-03-10
Maintains
Buy Buy
Piper Sandler
2026-02-19
Maintains
Neutral Neutral
Evercore ISI Group
2026-02-19
Maintains
In-Line In-Line
Truist Securities
2026-01-20
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning CHCT from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile